Xpeng Motors is a leading Chinese electric vehicle and technology company that designs and manufactures intelligent automobiles that are seamlessly integrated with the Internet and utilize the latest advances in artificial intelligence. Focusing on China’s young and tech-savvy consumer base, XPENG Motors strives to offer smart mobility solutions with technology innovation and cutting-edge R&D. The company’s initial backers include its CEO & Chairman He Xiaopeng, the founder of UCWeb Inc. and a former Alibaba executive. It was co-founded in 2014 by Henry Xia and He Tao, former senior executives at Guangzhou Auto with expertise in innovative automotive technology and R&D. It has received funding from prominent Chinese and international investors including Alibaba Group, Foxconn Group and IDG Capital. Currently with 3,000 employees, the company is headquartered in Guangzhou and has design, R&D, manufacturing and sales & marketing divisions in Silicon Valley, San Diego, Beijing, Shanghai, Zhaoqing (Guangdong Province) and Zhengzhou (Henan Province).
Dr. Gu is the Vice Chairman and President of XPeng Motors (NYSE: XPEV), a leading smart electric vehicle company in China. His main areas of responsibility at XPeng include strategy, finance, legal, investments, and globalization efforts. Since joining XPeng in 2018, Dr. Gu has successfully led many landmark capital raising activities for the company, totaling over $6.5 billion. These have included Xpeng’s listing debut on the New York Stock Exchange in 2020, raising $1.7 billion in one of 2020’s most successful US IPOs for a Chinese company, and the subsequent $2.5 billion follow-on issuance, the largest ever first-time follow-on ADS offering by a Chinese company, and its successful dual-primary listing at the Hong Kong Stock Exchange in July 2021, raising about $2 billion in less than a year since the company’s NYSE debut.
Prior to joining Xpeng, Dr. Gu was a managing director, Chairman of Asia Pacific Investment Banking and a member of the Global Strategic Advisory Council at J.P. Morgan, and was instrumental in building J.P. Morgan’s franchise in the Asia Pacific region. Between 1998-2004, Dr. Gu worked in the global M&A and global healthcare practice of Lehman Brothers in New York. During his 20-year investment banking career, Dr. Gu has advised numerous global leading companies on their strategy and landmark transactions, totaling over $200 billion in transaction volume.
Prior to his Wall Street career, Dr. Gu was a senior research scientist at the University of Washington Medical School. Dr. Gu is a member of the Greater China Advisory Committee of Yale School of Management, as well as a trustee of Yale China Association.
Dr. Gu holds an MBA from Yale University, a Ph.D. in Biochemistry from the University of Washington Medical School, and a bachelor degree in Chemistry from the University of Oregon.